News

The open-label, multiple-dose, dose-escalation study will also assess the impact of SNS01-T on time to relapse or progression and tumor response using multiple metrics. Senesco president and CEO

Qnexa is a once-a-day, oral investigational drug candidate which treats weight loss, type 2 diabetes and obstructive sleep apnea. FDA assigned a six-month, or class 2, review classification

APC-100 prevents the occurrence or recurrence of prostate cancer, the company claims. The drug is an orally available anti-androgenic/anti-inflammatory, signal transduction inhibitor which is said to have high

The funding is intended for improvements in manufacturing facility. Aoxing Pharma Chairman and CEO Zhenjiang Yue said the company is happy for the continued support from the government

GMOL is used in China to treat brain ischemia and infarction, coronary heart diseases, memory dysfunction and other neurological disorders. Gingko extracts mainly comprise flavonoids and terpenoids. Flavonoids

The data was published in November issue of the Journal of Sexual Medicine. Testim is a clear topical gel containing 1% testosterone, used to treat adult males who

Zybrestat selectively targets and collapses tumor vasculature, thereby depriving the tumor of oxygen and causing death of tumor cells. Falcon is a randomized, controlled Phase 2 study investigating

Veeva CRM will help HGS with all specialty care sales reps and medical science liaisons in Germany, Spain and France. According to HGS, Veeva’s pharmaceutical industry expertise and

Under the supply agreement, Z-Medica will supply QuikClot hemostatic products used in the interventional medical field to Premier member hospitals. This agreement will also provide access for specially